Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma (NCT02384434) | Clinical Trial Compass
CompletedNot Applicable
Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma
United States16 participantsStarted 2015-04-27
Plain-language summary
This study will assess the efficacy of LLLT to mitigate and ameliorate the acneiform-rash, radiation dermatitis, and pain, while assessing its impact on patient reported quality of life.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female patients ≥ 18 years of age
* Karnofsky performance status \> 70
* Histologic proof of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx
* No prior radiotherapy to the head and neck region.
* No previous systemic chemotherapy or targeted therapy
* Must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the nature of the therapy, alternatives, potential benefits, side-effects, risks and discomforts.
* Patients using standard therapies for cetuximab-induced acne-form rash will be included.
Exclusion Criteria:
* Evidence of distant metastasis on upright chest x-ray (CXR), computed tomography (CT) or other staging studies
* Any co-morbidity or condition of sufficient severity to limit full compliance with the protocol per assessment by the investigator
* Concurrent serious infection
* Continued use of Niacin